Infectious Disease In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Instruments, Reagents, Software), By Technology, By Application, By Test Location, By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Infectious Disease In Vitro Diagnostics Market: Methodology and Scope
                   1.1 Market Segmentation and Scope
                       1.1.1 Segment Definitions
                           1.1.1.1 Product
                           1.1.1.2 Technology
                           1.1.1.3 Application
                           1.1.1.4 Test Location
                   1.2 Regional Scope
                   1.3 Estimates and Forecast Timeline
                   1.4 Objectives
                       1.4.1 Objective - 1
                       1.4.2 Objective - 2
                       1.4.3 Objective - 3
                   1.5 Research Methodology
                   1.6 Information Procurement
                       1.6.1 Purchased Database
                       1.6.2 GVR’s Internal Database
                       1.6.3 Secondary Sources
                       1.6.4 Primary Research
                   1.7 Information or Data Analysis
                       1.7.1 Data Analysis Models
                   1.8 Market Formulation & Validation
                   1.9 Model Details
                       1.9.1 Commodity Flow Analysis
                   1.10 List of Secondary Sources
                   1.11 List of Abbreviations
Chapter 2 Infectious Disease In Vitro Diagnostics Market: Executive Summary
                   2.1 Market Outlook
                   2.2 Segment Insights
                   2.3 Competitive Insights
Chapter 3 Infectious Disease In Vitro Diagnostics Market: IVD Infectious Disease Market Variables, Trends & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent market outlook
                   3.2 Penetration and Growth Prospect Mapping
                   3.3 User Perspective Analysis
                       3.3.1 Consumer behavior analysis
                       3.3.2 Market influencer analysis
                       3.3.3 List of key end users
                   3.4 Market Dynamics
                       3.4.1 Market driver analysis
                           3.4.1.1 Growing geriatric population
                           3.4.1.2 Technological advancements
                           3.4.1.3 High demand for PoC facilities
                           3.4.1.4 Increasing prevalence of infectious diseases
                           3.4.1.5 External funding for R&D activities
                       3.4.2 Market restraint analysis
                           3.4.2.1 High prices of IVD tests
                       3.4.3 Industry challenges
                           3.4.3.1 Presence of ambiguous regulatory framework
                   3.5 IVD Infectious Disease Market Analysis Tools
                       3.5.1 Industry analysis - Porter’s
                       3.5.2 PESTLE Analysis
                       3.5.3 Market entry strategies
Chapter 4 IVD Infectious Diseases Market - Segment Analysis, By Product, 2018 - 2030 (USD Billion)
                   4.1 Global IVD Infectious Diseases Market: Test Type Movement Analysis
                   4.2 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       4.2.1 Instruments
                           4.2.1.1 Instruments market estimates and forecast, 2018 - 2030 (USD Billion)
                       4.2.2 Reagents
                           4.2.2.1 Reagents market estimates and forecast, 2018 - 2030 (USD Billion)
                       4.2.3 Software
                           4.2.3.1 Software market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 5 IVD Infectious Diseases Market - Segment Analysis, By Technology, 2018 - 2030 (USD Billion)
                   5.1 Global IVD Infectious Diseases Market: Technology Movement Analysis
                   5.2 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       5.2.1 Immunoassay
                           5.2.1.1 Immunoassay market estimates and forecast, 2018 - 2030 (USD Billion)
                       5.2.2 Molecular diagnostics
                           5.2.2.1 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
                           5.2.2.3 Polymerase Chain Reaction (PCR)
                               5.2.2.3.1 PCR market estimates and forecast, 2018 - 2030 (USD Billion)
                           5.2.2.4 In Situ Hybridization
                               5.2.2.4.1 In situ hybridization market estimates and forecast, 2018 - 2030 (USD Billion)
                           5.2.2.5 Isothermal Nucleic Acid Amplification Technology (INAAT)
                               5.2.2.5.1 INAAT market estimates and forecast, 2018 - 2030 (USD Billion)
                           5.2.2.6 Chips and Microarrays
                               5.2.2.6.1 Chips and microarrays market estimates and forecast, 2018 - 2030 (USD Billion)
                           5.2.2.7 Sequencing & NGS
                               5.2.2.7.1 Sequencing & NGS market estimates and forecast, 2018 - 2030 (USD Billion)
                           5.2.2.8 Transcription Mediated Amplification (TMA)
                               5.2.2.8.1 TMA market estimates and forecast, 2018 - 2030 (USD Billion)
                           5.2.2.9 Others
                               5.2.2.9.1 Others market estimates and forecast, 2018 - 2030 (USD Billion)
                       5.2.3 Microbiology
                           5.2.3.1 Microbiology market estimates and forecast, 2018 - 2030 (USD Billion)
                       5.2.4 Others
                           5.2.4.1 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 6 IVD Infectious Diseases Market - Segment Analysis, By Application, 2018 - 2030 (USD Billion)
                   6.1 Global IVD Infectious Diseases Market: Application Movement Analysis
                   6.2 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       6.2.1 MRSA
                           6.2.1.1 MRSA market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.2.2 Streptococcus
                           6.2.2.1 Streptococcus market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.2.3 Clostridium difficile
                           6.2.3.1 Clostridium difficile market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.2.4 Vancomycin-resistant enterococci (VRE)
                           6.2.4.1 VRE market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.2.5 Carbapenem-resistant enterobacterial testing (CRE)
                           6.2.5.1 CRE market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.2.6 Respiratory virus
                           6.2.6.1 Respiratory virus market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.2.7 Candida
                           6.2.7.1 Candida market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.2.8 Tuberculosis (TB) & drug-resistant TB
                           6.2.8.1 TB & drug-resistant TB market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.2.9 Gastrointestinal (GI) panel testing
                           6.2.9.1 GI panel testing market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.2.10 Chlamydia
                           6.2.10.1 Chlamydia market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.2.11 Gonorrhea
                           6.2.11.1 Gonorrhea market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.2.12 Human papillomavirus (HPV)
                           6.2.12.1 HPV market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.2.13 Human immunodeficiency virus (HIV)
                           6.2.13.1 HIV market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.2.14 Hepatitis C
                           6.2.14.1 Hepatitis C market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.2.15 Hepatitis B
                           6.2.15.1 Hepatitis B market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.2.16 COVID-19
                           6.2.16.1 COVID-19 market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.2.17 Others
                           6.2.17.1 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 7 IVD Infectious Diseases Market - Segment Analysis, By Test Location, 2018 - 2030 (USD Billion)
                   7.1 Global IVD Infectious Diseases Market: Test Location Movement Analysis
                   7.2 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       7.2.1 Point of Care
                           7.2.1.1 Point of Care market estimates and forecast, 2018 - 2030 (USD Billion)
                       7.2.2 Central laboratories
                           7.2.2.1 Central laboratories market estimates and forecast, 2018 - 2030 (USD Billion)
                       7.2.3 Others
                           7.2.3.1 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 8 IVD Infectious Diseases Market - Segment Analysis, By Region, 2018 - 2030 (USD Billion)
                   8.1 Regional Market Snapshot
                       8.1.1 North America
                           8.1.1.1 North America market estimates and forecast, 2018 - 2030 (USD Billion)
                           8.1.1.2 U.S.
                               8.1.1.2.1 U.S. IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.1.2.2 Key country dynamics
                               8.1.1.2.3 Disease prevalence
                               8.1.1.2.4 Regulatory framework
                               8.1.1.2.5 Competitive scenario
                           8.1.1.3 Canada
                               8.1.1.3.1 Canada IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.1.3.2 Key country dynamics
                               8.1.1.3.3 Disease prevalence
                               8.1.1.3.4 Regulatory framework
                               8.1.1.3.5 Competitive scenario
                       8.1.2 Europe
                           8.1.2.1 Europe market estimates and forecast, 2018 - 2030 (USD Billion)
                           8.1.2.2 UK
                               8.1.2.2.1 UK IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.2.2.2 Key country dynamics
                               8.1.2.2.3 Disease prevalence
                               8.1.2.2.4 Regulatory framework
                               8.1.2.2.5 Competitive scenario
                           8.1.2.3 Germany
                               8.1.2.3.1 Germany IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.2.3.2 Key country dynamics
                               8.1.2.3.3 Disease prevalence
                               8.1.2.3.4 Regulatory framework
                               8.1.2.3.5 Competitive scenario
                           8.1.2.4 Spain
                               8.1.2.4.1 Spain IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.2.4.2 Key country dynamics
                               8.1.2.4.3 Disease prevalence
                               8.1.2.4.4 Regulatory framework
                               8.1.2.4.5 Competitive scenario
                           8.1.2.5 France
                               8.1.2.5.1 France IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.2.5.2 Key country dynamics
                               8.1.2.5.3 Disease prevalence
                               8.1.2.5.4 Regulatory framework
                               8.1.2.5.5 Competitive scenario
                           8.1.2.6 Italy
                               8.1.2.6.1 Italy IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.2.6.2 Key country dynamics
                               8.1.2.6.3 Disease prevalence
                               8.1.2.6.4 Regulatory framework
                               8.1.2.6.5 Competitive scenario
                           8.1.2.7 Denmark
                               8.1.2.7.1 Denmark IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.2.7.2 Key country dynamics
                               8.1.2.7.3 Disease prevalence
                               8.1.2.7.4 Regulatory framework
                               8.1.2.7.5 Competitive scenario
                           8.1.2.8 Sweden
                               8.1.2.8.1 Sweden IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.2.8.2 Key country dynamics
                               8.1.2.8.3 Disease prevalence
                               8.1.2.8.4 Regulatory framework
                               8.1.2.8.5 Competitive scenario
                           8.1.2.9 Norway
                               8.1.2.9.1 Norway IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.2.9.2 Key country dynamics
                               8.1.2.9.3 Disease prevalence
                               8.1.2.9.4 Regulatory framework
                               8.1.2.9.5 Competitive scenario
                       8.1.3 Asia Pacific
                           8.1.3.1 Asia Pacific market estimates and forecast estimates and forecast, 2018 - 2030 (USD Billion)
                           8.1.3.2 Japan
                               8.1.3.2.1 Japan IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.3.2.2 Key country dynamics
                               8.1.3.2.3 Disease prevalence
                               8.1.3.2.4 Regulatory framework
                               8.1.3.2.5 Competitive scenario
                           8.1.3.3 China
                               8.1.3.3.1 China IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.3.3.2 Key country dynamics
                               8.1.3.3.3 Disease prevalence
                               8.1.3.3.4 Regulatory framework
                               8.1.3.3.5 Competitive scenario
                           8.1.3.4 India
                               8.1.3.4.1 India IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.3.4.2 Key country dynamics
                               8.1.3.4.3 Disease prevalence
                               8.1.3.4.4 Regulatory framework
                               8.1.3.4.5 Competitive scenario
                           8.1.3.5 South Korea
                               8.1.3.5.1 South Korea IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.3.5.2 Key country dynamics
                               8.1.3.5.3 Disease prevalence
                               8.1.3.5.4 Regulatory framework
                               8.1.3.5.5 Competitive scenario
                           8.1.3.6 Australia
                               8.1.3.6.1 Australia IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.3.6.2 Key country dynamics
                               8.1.3.6.3 Disease prevalence
                               8.1.3.6.4 Regulatory framework
                               8.1.3.6.5 Competitive scenario
                           8.1.3.7 Thailand
                               8.1.3.7.1 Thailand IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.3.7.2 Key country dynamics
                               8.1.3.7.3 Disease prevalence
                               8.1.3.7.4 Regulatory framework
                               8.1.3.7.5 Competitive scenario
                       8.1.4 Latin America
                           8.1.4.1 Latin America market estimates and forecast estimates and forecast, 2018 - 2030 (USD Billion)
                           8.1.4.2 Brazil
                               8.1.4.2.1 Brazil IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.4.2.2 Key country dynamics
                               8.1.4.2.3 Disease prevalence
                               8.1.4.2.4 Regulatory framework
                               8.1.4.2.5 Competitive scenario
                           8.1.4.3 Mexico
                               8.1.4.3.1 Mexico IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.4.3.2 Key country dynamics
                               8.1.4.3.3 Disease prevalence
                               8.1.4.3.4 Regulatory framework
                               8.1.4.3.5 Competitive scenario
                           8.1.4.4 Argentina
                               8.1.4.4.1 Argentina IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.4.4.2 Key country dynamics
                               8.1.4.4.3 Disease prevalence
                               8.1.4.4.4 Regulatory framework
                               8.1.4.4.5 Competitive scenario
                       8.1.5 MEA
                           8.1.5.1 MEA market estimates and forecast estimates and forecast, 2018 - 2030 (USD Billion)
                           8.1.5.2 South Africa
                               8.1.5.2.1 South Africa IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.5.2.2 Key country dynamics
                               8.1.5.2.3 Disease prevalence
                               8.1.5.2.4 Regulatory framework
                               8.1.5.2.5 Competitive scenario
                           8.1.5.3 Saudi Arabia
                               8.1.5.3.1 Saudi Arabia IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.5.3.2 Key country dynamics
                               8.1.5.3.3 Disease prevalence
                               8.1.5.3.4 Regulatory framework
                               8.1.5.3.5 Competitive scenario
                           8.1.5.4 UAE
                               8.1.5.4.1 UAE IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.5.4.2 Key country dynamics
                               8.1.5.4.3 Disease prevalence
                               8.1.5.4.4 Regulatory framework
                               8.1.5.4.5 Competitive scenario
                           8.1.5.5 Kuwait
                               8.1.5.5.1 Kuwait IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                               8.1.5.5.2 Key country dynamics
                               8.1.5.5.3 Disease prevalence
                               8.1.5.5.4 Regulatory framework
                               8.1.5.5.5 Competitive scenario
Chapter 9 COMPETITIVE LANDSCAPE
                   9.1 Company Categorization
                   9.2 Strategy Mapping
                       9.2.1 New product launch
                       9.2.2 Partnerships
                       9.2.3 Acquisition
                       9.2.4 Collaboration
                   9.3 Key company market share analysis, 2022
                   9.4 Company Profiles
                       9.4.1 BD
                           9.4.1.1 Company overview
                           9.4.1.2 Financial performance
                           9.4.1.3 Product benchmarking
                           9.4.1.4 Strategic initiatives
                       9.4.2 bioMérieux SA
                           9.4.2.1 Company overview
                           9.4.2.2 Financial performance
                           9.4.2.3 Product benchmarking
                           9.4.2.4 Strategic initiatives
                       9.4.3 Abbott
                           9.4.3.1 Company overview
                           9.4.3.2 Financial performance
                           9.4.3.3 Product benchmarking
                           9.4.3.4 Strategic initiatives
                       9.4.4 Quidel Corporation
                           9.4.4.1 Company overview
                           9.4.4.2 Financial performance
                           9.4.4.3 Product benchmarking
                           9.4.4.4 Strategic initiatives
                       9.4.5 OraSure Technologies, Inc
                           9.4.5.1 Company overview
                           9.4.5.2 Financial performance
                           9.4.5.3 Product benchmarking
                           9.4.5.4 Strategic initiatives
                       9.4.6 Hologic Inc. (Gen Probe)
                           9.4.6.1 Company overview
                           9.4.6.2 Financial performance
                           9.4.6.3 Product benchmarking
                           9.4.6.4 Strategic initiatives
                       9.4.7 Cepheid (Danaher)
                           9.4.7.1 Company overview
                           9.4.7.2 Financial performance
                           9.4.7.3 Product benchmarking
                           9.4.7.4 Strategic initiatives
                       9.4.8 QIAGEN
                           9.4.8.1 Company overview
                           9.4.8.2 Financial performance
                           9.4.8.3 Product benchmarking
                           9.4.8.4 Strategic initiatives
                       9.4.9 F. Hoffmann-La Roche Ltd.
                           9.4.9.1 Company overview
                           9.4.9.2 Financial performance
                           9.4.9.3 Product benchmarking
                           9.4.9.4 Strategic initiatives
                       9.4.10 Siemens Healthcare GmbH
                           9.4.10.1 Company overview
                           9.4.10.2 Financial performance
                           9.4.10.3 Product benchmarking
                           9.4.10.4 Strategic initiatives
                       9.4.11 Bio-Rad Laboratories, Inc.
                           9.4.11.1 Company overview
                           9.4.11.2 Financial performance
                           9.4.11.3 Product benchmarking
                           9.4.11.4 Strategic initiatives

List of Tables

TABLE 1 List of Secondary Sources
TABLE 2 List of Abbreviations
TABLE 3 Regulatory Framework
TABLE 4 Global IVD Infectious Diseases Market, By Region, 2018 - 2030 (USD Billion)
TABLE 5 Global IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 6 Global IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 7 Global IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 8 Global IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 9 North America IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Billion)
TABLE 10 North America IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 11 North America IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 12 North America IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 13 North America IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 14 U.S. IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 15 U.S. IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 16 U.S. IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 17 U.S. IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 18 Canada IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 19 Canada IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 20 Canada IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 21 Canada IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 22 Europe IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Billion)
TABLE 23 Europe IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 24 Europe IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 25 Europe IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 26 Europe IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 27 U.K. IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 28 U.K. IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 29 U.K. IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 30 U.K. IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 31 Germany IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 32 Germany America IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 33 Germany America IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 34 Germany America IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 35 France IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 36 France IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 37 France IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 38 France IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 39 Spain IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 40 Spain IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 41 Spain IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 42 Spain IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 43 Italy IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 44 Italy IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 45 Italy IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 46 Italy IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 47 Denmark IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 48 Denmark IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 49 Denmark IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 50 Denmark IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 51 Sweden IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 52 Sweden IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 53 Sweden IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 54 Sweden IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 55 Norway IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 56 Norway IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 57 Norway IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 58 Norway IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 59 Asia Pacific IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Billion)
TABLE 60 Asia Pacific IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 61 Asia Pacific IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 62 Asia Pacific IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 63 Asia Pacific IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 64 China IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 65 China IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 66 China IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 67 China IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 68 Japan IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 69 Japan IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 70 Japan IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 71 Japan IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 72 India IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 73 India IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 74 India IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 75 India IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 76 South Korea IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 77 South Korea IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 78 South Korea IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 79 South Korea IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 80 Thailand IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 81 Thailand IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 82 Thailand IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 83 Thailand IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 84 Australia IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 85 Australia IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 86 Australia IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 87 Australia IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 88 Latin America IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Billion)
TABLE 89 Latin America IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 90 Latin America IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 91 Latin America IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 92 Latin America IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 93 Brazil IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 94 Brazil IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 95 Brazil IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 96 Brazil IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 97 Mexico IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 98 Mexico IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 99 Mexico IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 100 Mexico IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 101 Argentina IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 102 Argentina IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 103 Argentina IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 104 Argentina IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 105 MEA IVD Infectious Diseases Market, By Country, 2018 - 2030 (USD Billion)
TABLE 106 MEA IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 107 MEA IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 108 MEA IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 109 MEA IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 110 South Africa IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 111 South Africa IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 112 South Africa IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 113 South Africa IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 114 UAE IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 115 UAE IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 116 UAE IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 117 UAE IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 118 Saudi Arabia IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 119 Saudi Arabia IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 120 Saudi Arabia IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 121 Saudi Arabia IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)
TABLE 122 Kuwait IVD Infectious Diseases Market, By Product, 2018 - 2030 (USD Billion)
TABLE 123 Kuwait IVD Infectious Diseases Market, By Technology, 2018 - 2030 (USD Billion)
TABLE 124 Kuwait IVD Infectious Diseases Market, By Application, 2018 - 2030 (USD Billion)
TABLE 125 Kuwait IVD Infectious Diseases Market, By Test Location, 2018 - 2030 (USD Billion)

List of Figures

FIG. 1 IVD infectious diseases market segmentation
FIG. 2 Market research process
FIG. 3 Information procurement
FIG. 4 Primary research pattern
FIG. 5 Primary interviews in North America
FIG. 6 Primary interviews in Europe
FIG. 7 Primary interviews in Asia Pacific
FIG. 8 Primary interviews in Middle East and Africa
FIG. 9 Market research approaches
FIG. 10 Value-chain-based sizing & forecasting
FIG. 11 QFD modeling for market share assessment
FIG. 12 Market formulation & validation
FIG. 13 IVD infectious disease market snapshot
FIG. 14 Segment Insights
FIG. 15 Strategy framework
FIG. 16 Penetration & growth prospect mapping
FIG. 17 Consumer behavior analysis
FIG. 18 Factors influencing North America IVD infectious diseases market (%)
FIG. 19 Factors influencing Europe IVD infectious diseases market (%)
FIG. 20 Factors influencing Asia Pacific IVD infectious diseases market (%)
FIG. 21 Factors influencing Latin America IVD infectious diseases market (%)
FIG. 22 Factors influencing Middle East and Africa IVD infectious diseases market (%)
FIG. 23 Market driver relevance analysis (Current & future impact)
FIG. 24 Global population growth, by age-group, 2012 - 2022 (Million)
FIG. 25 Global percentage of population, by age group, 2000 and 2050
FIG. 26 General trend of CLIA-waived tests
FIG. 27 Market restraint relevance analysis (Current & future impact)
FIG. 28 Porter’s five forces analysis
FIG. 29 PESTLE analysis
FIG. 30 Strategy mapping
FIG. 31 IVD infectious diseases market: Product movement analysis
FIG. 32 Product segment dashboard
FIG. 33 IVD infectious diseases market product outlook: Key takeaways
FIG. 34 Instruments market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 35 Reagents market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 36 Software market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 37 IVD infectious diseases market: Technology movement analysis
FIG. 38 Technology segment dashboard
FIG. 39 IVD infectious diseases market technology outlook: Key takeaways
FIG. 40 Immunoassay market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 41 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 42 PCR market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 43 In Situ Hybridization market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 44 INAAT market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 45 Chips and microarrays market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 46 Sequencing & NGS market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 47 TMA market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 48 Others market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 49 Microbiology market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 50 Others market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 51 IVD infectious diseases market: Technology movement analysis
FIG. 52 Application segment dashboard
FIG. 53 IVD infectious diseases market technology outlook: Key takeaways
FIG. 54 MRSA market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 55 Streptococcus market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 56 Clostridium difficile market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 57 VRE market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 58 CRE market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 59 Respiratory virus market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 60 Candida market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 61 TB & drug-resistant TB market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 62 GI panel testing market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 63 Chlamydia market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 64 Gonorrhea market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 65 HPV market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 66 HIV market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 67 Hepatitis C market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 68 Hepatitis B market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 69 COVID-19 market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 70 Others market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 71 IVD infectious diseases market: Test location movement analysis
FIG. 72 Test location segment dashboard
FIG. 73 IVD infectious diseases market test location outlook: Key takeaways
FIG. 74 Point of Care market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 75 Central laboratories market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 76 Others market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 77 Regional outlook, 2022 & 2030
FIG. 78 Regional market dashboard
FIG. 79 Regional marketplace: Key takeaways
FIG. 80 North America market share and leading players, 2022
FIG. 81 Europe market share and leading players, 2022
FIG. 82 Asia Pacific market share and leading players, 2022
FIG. 83 Latin America market share and leading players, 2022
FIG. 84 Middle East and Africa market share and leading players, 2022
FIG. 85 North America, SWOT
FIG. 86 Europe, SWOT
FIG. 87 Asia Pacific, SWOT
FIG. 88 Latin America, SWOT
FIG. 89 Middle East and Africa, SWOT
FIG. 90 North America IVD infectious diseases market, 2018 - 2030 (USD Billion)
FIG. 91 U.S. key country dynamics
FIG. 92 U.S. IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 93 Canada key country dynamics
FIG. 94 Canada IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 95 Europe IVD infectious diseases market, 2018 - 2030 (USD Billion)
FIG. 96 UK key country dynamics
FIG. 97 UK IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 98 Germany key country dynamics
FIG. 99 Germany IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 100 Spain key country dynamics
FIG. 101 Spain IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 102 France key country dynamics
FIG. 103 France IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 104 Italy key country dynamics
FIG. 105 Italy IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 106 Denmark key country dynamics
FIG. 107 Denmark IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 108 Sweden key country dynamics
FIG. 109 Sweden IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 110 Norway key country dynamics
FIG. 111 Norway IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 112 Asia Pacific IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 113 Japan key country dynamics
FIG. 114 Japan IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 115 China key country dynamics
FIG. 116 China IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 117 India key country dynamics
FIG. 118 India IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 119 South Korea key country dynamics
FIG. 120 South Korea IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 121 Australia key country dynamics
FIG. 122 Australia IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 123 Thailand key country dynamics
FIG. 124 Thailand IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 125 Latin America IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 126 Brazil key country dynamics
FIG. 127 Brazil IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 128 Mexico key country dynamics
FIG. 129 Mexico IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 130 Argentina key country dynamics
FIG. 131 Argentina IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 132 MEA IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 133 South Africa key country dynamics
FIG. 134 South Africa IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 135 Saudi Arabia key country dynamics
FIG. 136 Saudi Arabia IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 137 UAE key country dynamics
FIG. 138 UAE IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 139 Kuwait key country dynamics
FIG. 140 Kuwait IVD infectious diseases market estimates and forecast, 2018 - 2030 (USD Billion)
FIG. 141 Ansoff Matrix
FIG. 142 Heat map analysis
FIG. 143 Company market share analysis
FIG. 144 Company market position analysis
FIG. 145 Company market share, by region, 2022
FIG. 146 Market differentiators